WL

William Lay

Melodiol Global Health Limited | Chief Executive Officer, Managing Director
Mr Lay is a cannabis executive and previously served as Executive Vice President - Strategy, Origination & Operations at Melodiol. Mr Lay began his career with Canadian full service financial investment bank, BMO Capital Markets through roles across Canada and London. During his time with BMO Capital Markets, Mr Lay participated in M&A, equity financing and debt financing transactions totaling >C$3 bn in cumulative value. Shortly after his time with BMO Capital Markets, Mr Lay joined Canopy Growth Corporation (TSE: WEED, NASDAQ: CGC) as an M&A Associate, before being promoted to Associate Director, M&A, in 2019. In this role, he assessed and effected transactions locally and internationally, while progressing corporate strategy initiatives across the group. Over the last six years, Mr Lay has managed and supported over C$5 billion in cannabis M&A transactions.

Company and Roles

Company
Title
Tenure
Since
ME1
Melodiol Global Health Limited
  • Chief Executive Officer
  • Managing Director
2yrs, 10mthJan 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ME1
Melodiol Global Health Limited
06/09/24N/A42,500,00010,488N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ME1
Melodiol Global Health Limited
06/09/24
Expiry
33,334$0.001$33Options expired
ME1
Melodiol Global Health Limited
17/01/24
Expiry
10,000,000$0.001$10,000Options expired
ME1
Melodiol Global Health Limited
17/01/24
Expiry
7,500,000$0.001$7,500As advised by the company
ME1
Melodiol Global Health Limited
13/11/23
Issued
2,125,000$0.002$4,250Prospectus
ME1
Melodiol Global Health Limited
02/11/23
Issued
5,000,000$0.003$15,000Conversion of securities